---
document_datetime: 2026-01-09 15:09:42
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/usymro-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: usymro-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.3416218
conversion_datetime: 2026-01-10 11:41:21.03245
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Usymro

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 09/01/2026                          |                                             | Labelling                        |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000316073                                        | Update of the product information to remove all text in sections '1. Name of the medicinal product', '2. Name of the marketing authorisation holder' and '5. Other' of the 'Minimum particulars to appear on blisters or strips' in the labelling for the 45 mg and 90 mg pre-filled syringe blister pack (EU/1/25/1957/002-003).   |            |            |                        |
|---------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| Variation type IA_IN / EMA/VR/0000310110                | B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.1 Not including batch control/testing - Accepted                                                                                                                                                                 | 05/11/2025 |            | Annex II and PL        |
| Marketing Authorisation Transfer - H / EMA/T/0000295328 | - Transfer of a marketing authorisation - transfer of marketing authorisation from Elc Group s.r.o. to Gedeon Richter Plc.                                                                                                                                                                                                          | 25/09/2025 | 24/10/2025 | SmPC, Labelling and PL |